Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Paul A. Chervenick"'
Autor:
J. Raychaudhuri, Ling Zhang, Lia Perez, Ernesto Ayala, Rachid Baz, Salvador Bruno, Jennifer L. Cultrera, Eduardo M. Sotomayor, Lubomir Sokol, Jane Jijun Liu, Teresa Field, Paul A. Chervenick, Jose L. Ochoa-Bayona, Celeste M. Bello, Mohamed A. Kharfan-Dabaja
Publikováno v:
Leukemia Research. 35:1571-1577
Plasmablastic lymphoma (PBL) is a rare aggressive B-cell lymphoproliferative disorder. HIV-negative PBL has not been extensively reported. Nine HIV-negative PBL patients evaluated at Moffitt Cancer Center were studied. Eight patients had extranodal d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1c32a039953cfb87f60ec490e80c54c
https://doi.org/10.1016/j.leukres.2011.06.023
https://doi.org/10.1016/j.leukres.2011.06.023
Publikováno v:
Asian cardiovascularthoracic annals. 25(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba064782691120ede26bed32a217c0f4
https://pubmed.ncbi.nlm.nih.gov/26124435
https://pubmed.ncbi.nlm.nih.gov/26124435
Autor:
Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Samir Dalia, Lubomir Sokol, Celeste M. Bello, Eduardo M. Sotomayor, Joseph Clara, Luis Miguel Juarez Salcedo, Paul A. Chervenick, Bijal D. Shah
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S106-S107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63cb8adc01a296b1a2eb79fb940fef01
https://doi.org/10.1016/j.clml.2016.07.153
https://doi.org/10.1016/j.clml.2016.07.153
Autor:
Jose D Sandoval-Sus, Paola Parra, Celeste M. Bello, Eduardo M. Sotomayor, Paul A. Chervenick, Bijal D. Shah, Lubomir Sokol, Jeffrey E. Lancet, Ernesto Ayala, Julio C. Chavez, Frederick L. Locke, Mohamed A. Kharfan-Dabaja
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S115-S116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e964beef3bfb97cc094e14bf1a600b03
https://doi.org/10.1016/j.clml.2016.07.167
https://doi.org/10.1016/j.clml.2016.07.167
Autor:
Bijal D. Shah, Celeste M. Bello, Paul A. Chervenick, Rami S. Komrokji, Samir Dalia, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Joseph Clara, Eduardo M. Sotomayor, Lubomir Sokol, Emilie Wang
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:S376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f80116420c88966db3e64973b04d9deb
https://doi.org/10.1016/j.clml.2017.07.218
https://doi.org/10.1016/j.clml.2017.07.218
Autor:
Bijal D. Shah, Bryan J Little, Samir Dalia, Lubomir Sokol, Ji-Hyun Lee, Julio C. Chavez, Kate Fisher, Celeste M. Bello, Paul A. Chervenick, Eduardo M. Sotomayor
Publikováno v:
Annals of hematology. 93(8)
Serum albumin (SA) has been shown to be a prognostic marker in many hematological malignancies and in diffuse large B-cell lymphoma (DLBCL) prior to chemo-immunotherapy. SA may be a surrogate for age, comorbid status, and disease severity. Here, we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::695c4046686a1884723c881e592c8b2e
https://pubmed.ncbi.nlm.nih.gov/24590536
https://pubmed.ncbi.nlm.nih.gov/24590536
Autor:
Jose D Sandoval-Sus, Lubomir Sokol, Eduardo M. Sotomayor, Andrew T. Kuykendall, Samir Dalia, Bijal D. Shah, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Chetasi Talati, Celeste M. Bello, Ernesto Ayala, Frederick L. Locke, Jori Kaplan, Farhad Khimani, Paul A. Chervenick
Publikováno v:
Blood. 128:1870-1870
Background: MYC positive double hit lymphomas (DHL) (presence of c-myc and BCL2 or BCL6 rearrangements by florescence in situ hybridization (FISH) analysis) and double protein expressor lymphomas (DEL) (protein expression by immunohistochemistry (IHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::660d8e291ccc5fd33e0cb113a1d1adb4
https://doi.org/10.1182/blood.v128.22.1870.1870
https://doi.org/10.1182/blood.v128.22.1870.1870
Autor:
Andrew T. Kuykendall, Bijal D. Shah, Samir Dalia, Eduardo M. Sotomayor, Frederick L. Locke, Celeste M. Bello, Chetasi Talati, Ernesto Ayala, Paul A. Chervenick, Jose D Sandoval-Sus, Jori Kaplan, Julio C. Chavez, Mohamed A. Kharfan-Dabaja, Lubomir Sokol
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19646eaa1c766f734b68fa92109e84e5
https://doi.org/10.1016/j.clml.2016.07.142
https://doi.org/10.1016/j.clml.2016.07.142
Autor:
Eduardo M. Sotomayor, Celeste M. Bello, Jose Sandoval-Sus, Paul A. Chervenick, Samantha Shams, Patrick T. Griffin, Mohamed A. Kharfan-Dabaja, Bijal D. Shah, Ernesto Ayala, Luis Miguel Juárez Salcedo, Lubomir Sokol, Julio C. Chavez
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:S116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baea3facac0279d93a05912d43578c3e
https://doi.org/10.1016/j.clml.2016.07.168
https://doi.org/10.1016/j.clml.2016.07.168
Autor:
Eduardo M. Sotomayor, Celeste M. Bello, Jeffrey E. Lancet, Chetasi Talati, Javier Pinilla-Ibarz, Jose Sandoval-Sus, Bijal D. Shah, Frederick L. Locke, Paul A. Chervenick, Samir Dalia, Julio C. Chavez, Lubomir Sokol, Mohamed A. Kharfan-Dabaja
Publikováno v:
Journal of Clinical Oncology. 34:7534-7534
7534Background: Genetic abnormalities in chronic lymphocytic leukemia (CLL) have prognostic impact. The presence of trisomy 12 (T12) and normal karyotype (NK), and 13q deletion (del13q) are associated with an intermediate and good risk profile in CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::998848e81e87530bd9aadac1e6fff798
https://doi.org/10.1200/jco.2016.34.15_suppl.7534
https://doi.org/10.1200/jco.2016.34.15_suppl.7534